CD40L/CD154 Monoklonaler Antikörper
CD40L/CD154 Monoklonal Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human, Ratte
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1E6D10
Kat-Nr. : 66502-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66502-1-PBS bindet in WB, Indirect ELISA CD40L/CD154 und zeigt Reaktivität mit human, Ratten
Getestete Reaktivität | human, Ratte |
Wirt / Isotyp | Maus / IgG2a |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | CD40L/CD154 fusion protein Ag24941 |
Vollständiger Name | CD40 ligand |
Berechnetes Molekulargewicht | 261 aa, 29 kDa |
Beobachtetes Molekulargewicht | 30 kDa |
GenBank-Zugangsnummer | BC071754 |
Gene symbol | CD40 Ligand |
Gene ID (NCBI) | 959 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The CD40 ligand (CD40L, TRAP, CD154), a member of the TNF superfamily of ligands, is expressed as either a 33-kd transmembrane homologue or 18-kd soluble form (sCD154). CD40L is primarily expressed on activated CD4+ T cells and on a small proportion of CD8+ T cells and platelets. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. Recent studies have suggested that CD40/CD40L interactions regulate oxidative stress and affect various signaling pathways in both the immunological and the cardiovascular systems. The CD40/CD40L system is also involved in tumorigenesis. Its expression is tightly regulated, and abnormal levels of CD40L are associated with the pathogenesis of atheromatous plaque destabilization and thrombotic events. Multiple mutations in CD40LG gene have been identified that are associated with hyper-IgM immunodeficiency syndrome type 1.